Has the new sexual desire drug panned out?
Image: iStock
About the drug
Flibanserin has been shown to modestly improve sexual function—10% compared with placebo—among premenopausal women with hypoactive sexual desire disorder (HSDD), a severe lack of interest in sex. Flibanserin is different from sildenafil (Viagra) for men, which is taken on demand (just before sex) and acts by improving blood flow to the penis. Flibanserin must be taken daily, and it targets the brain area that regulates sexuality. Flibanserin has the potential for serious side effects, including very low blood pressure, fainting, and nausea. These risks increase and become even more severe if a woman drinks alcohol or is taking birth control pills.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online Plus (HHO+) to unlock expert-backed health insights, personalized tools, and exclusive resources to feel your best every day.
Here’s what you get with your HHO+ membership:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
I’d like to subscribe to HHO+ for $4.99/month to access expert-backed content to help make smart, informed decisions about my well-being.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
